盖尔模型及其在预防查中的使用:对科尔贝利研究进行比较
William R Pruitt1, Beryl Samuels2, Scott Cunningham3
1Preventive Medicine, Oceania University of Medicine, Apia, WSM.
Cureus
|March 19, 2024
概括
只有38%的受访医生使用盖尔模型来评估乳腺癌风险. 这项研究强调了利用这种工具用于早期乳腺癌检测和预防策略的差距.
科学领域:
- 在瘤学瘤学.
- 预防医学 预防医学
- 主要护理是指初级护理.
背景情况:
- 盖尔模型是一种用来评估女性患乳腺癌的风险的工具.
- 盖尔分数为1.66%或更高意味着风险增加.
- 了解医生对盖尔模型的利用对于有效的乳腺癌查至关重要.
研究的目的:
- 为了确定盖尔模型的频率,德克萨斯州的初级保健医生在乳腺癌查中使用该模型.
- 为了比较不同专业的使用率:内科,家庭医学和妇科.
主要方法:
- 一项调查对德克萨斯州希达尔戈和约翰逊县的100名医生进行了调查.
- 该调查收集了关于盖尔模型和化疗预防使用频率的数据.
- 数据分析包括描述性统计和费舍尔的确切概率测试.
主要成果:
- 实现了34%的响应率 (100名医生中34名医生).
- 只有38%的受访者报告在他们的实践中使用盖尔模型.
- 医生使用量因专业而异:46% (IM),23% (FM) 和31% (GYN).
结论:
- 少数初级保健医生使用盖尔模型来降低乳腺癌风险.
- 需要进一步的研究来优化盖尔模型在乳腺癌预防中的应用.
- 尽量减少降低风险的药物的副作用对于患者的坚持是必不可少的.
相关概念视频
Bias in Epidemiological Studies
259
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
259
Study Designs in Epidemiology
215
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
215
Prevalence and Incidence
493
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
493
Comparing the Survival Analysis of Two or More Groups
183
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
183
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Relative Risk
163
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
163


